Tag: update

VANCOUVER, BC, June 15, 2026 /CNW/ - EMP Metals Corp. (CSE: EMPS) (OTCQB: EMPPF) ("EMP Metals" or the "Company") is pleased to announce that...

TSX and OTC: MPVDTORONTO and NEW YORK, June 15, 2026 /PRNewswire/ -- Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) and (OTC: MPVD) announces today that it has completed...

TSX and OTC: MPVDTORONTO and NEW YORK, June 15, 2026 /CNW/ - Mountain Province Diamonds Inc. ("Mountain Province" or the "Company") (TSX: MPVD) and (OTC: MPVD) announces today that it has completed...

Mark Bishop Appointed Chief Monetization Officer, Blue Ant Rights & Streaming; Matt Hornburg Appointed Chief Content Officer, Blue Ant Studios TORONTO, June 15, 2026 /CNW/...

STAMFORD, Conn., June 15, 2026 (GLOBE NEWSWIRE) -- The Lovesac Co. (NASDAQ: LOVE), the Designed for Life home and technology brand best known for its Sactionals, The World's Most Adaptable Couch, today announced it has appointed Andrew Farag as the Company’s Executive Vice President, Chief Financial Officer and Treasurer, effective immediately. He succeeds Keith Siegner who has stepped down from the role but will remain with the Company for a short period to support the transition.

CHICAGO, June 15, 2026 (GLOBE NEWSWIRE) -- Mondelēz International (Nasdaq: MDLZ) today announced the appointment of Amit Banati as Executive Vice President and Chief Financial Officer, effective July 1, 2026. He will report directly to Dirk Van de Put, Chair and Chief Executive Officer, and will be a member of the Mondelēz International Leadership Team. Following Banati’s appointment, Luca Zaramella will continue as Executive Vice President and Chief Operating Officer, focusing his leadership on the Company’s commercial operations, including its four geographical regions, corporate sales, marketing and supply chain functions.

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

MRD has scaled into a profitable, category-leading MRD diagnostics business, while Immune Medicine has built a differentiated discovery platform powered by proprietary immune data and AI

SAN FRANCISCO, June 15, 2026 (GLOBE NEWSWIRE) -- Allbirds, Inc. (NASDAQ: BIRD) previously announced that the Company intends to make a distribution, in the form of a special dividend, to stockholders of record of a portion of the proceeds from the previously disclosed Asset Sale (such special dividend, the “Asset Sale Dividend”). The Company announced today that the Board of Directors of the Company has established June 25, 2026, as the record date for the stockholders of the Company entitled to receive the Asset Sale Dividend, with the payment of the Asset Sale Dividend to occur within 60 days of such record date.

RADNOR, Pa., June 15, 2026 /PRNewswire/ -- Pardee Resources Company (OTC: PDER) (the "Company") announced today that it has entered into a definitive agreement...

Target-specific licensing agreement enabling Antharis to advance proprietary dual-payload antibody-drug conjugate (ADC) programs using Lonza's site-specific ADC technologiesReinforces Antharis' and Lonza's position at the forefront...

ST. JOHN'S, NL, June 15, 2026 /CNW/ - Aurion Resources Ltd. (TSXV: AU) (OTCQX: AIRRF) ("Aurion") is pleased to announce the successful completion of the previously...